Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis: Association with smoking

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 7-8, 2012, Pages 320-325

  Urbankowski, Tomasz ^a   Hoser, Grazyna ^b   Domagała Kulawik, Joanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Bronchoalveolar lavage; Cytokines; Sarcoidosis; Smoking

Indexed keywords

CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LIMIT OF DETECTION; LUNG FLUID; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SARCOIDOSIS; SMOKING;

EID: 84866096821     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1341     Document Type: Article

References (29)

1. Rowińska-Zakrzewska E, Bestry I. [Interstitial lung diseases]. In: Szczeklik A, ed. [Internal diseases - 2011 update]. Kraków, Poland: Medycyna Praktyczna; 2011: 644-648. Polish.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999; 160: 736-755.
3. Grutters JC, Drent M, van den Bosch JM. Sarcoidosis. In: du Bois RM, Richeldi L, eds. Interstitial Lung Diseases (European Respiratory Society Monograph): European Respiratory Society Journals Ltd; 2009: 126-154.
4. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007 22; 357: 2153-2165.
5. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med. 2001; 7: 255-261.
6. Kieszko R, Krawczyk P, Chocholska S, et al. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis. Respir Med. 2007; 101: 645-654.
7. Semenzato G, Bortoli M, Brunnetta E, et al. Immunology and pathophysiology. In: Drent M, Costabel U, eds. Sarcoidosis (European Respiratory Society Monograph): European Respiratory Society Journals Ltd; 2005: 49-63.
8. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006; 18: 349-356.
9. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007; 204: 1849-1861.
10. Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology. 2009; 126: 177-185.
11. Facco M, Cabrelle A, Teramo A, et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 2011; 66: 144-150.
12. Ten Berge B, Paats MS, Bergen IM, et al. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology (Oxford). 2012; 51: 37-46.
13. Douglas JG, Middleton WG, Gaddie J, et al. Sarcoidosis: a disorder commoner in non-smokers? Thorax. 1986; 41: 787-791.
14. Hance AJ, Basset F, Saumon G, et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci. 1986; 465: 643-656.
15. Harf RA, Ethevenaux C, Gleize J, et al. Reduced prevalence of smokers in sarcoidosis. Results of a case-control study. Ann N Y Acad Sci. 1986; 465: 625-631.
16. Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988; 43: 516-524.
17. Domagala-Kulawik J. Effects of cigarette smoke on the lung and systemic immunity. J Physiol Pharmacol. 2008; 59 (Suppl 6): 19-34.
18. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971; 20: 1637-1648.
19. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975; 59: 365-372.
20. Chcialowski A, Chorostowska-Wynimko J, Fal A, et al. [Recommendation of the Polish Respiratory Society for bronchoalveolar lavage (BAL) sampling, processing and analysis methods]. Pneumonol Alergol Pol. 2011; 79: 75-89. Polish.
21. Urbankowski T, Knyziak-Mȩdrzycka I, Domagala-Kulawik J, et al. Sarcoidosis and tobacco smoking: clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition. Pol Merkur Lekarski. 2012; 32: 298-301.
22. Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med. 2007; 28: 486-495.
23. Losa García JE, Rodríguez FM, Martín de Cabo MR, et al. Evaluation of inflammatory cytokine secretion by human alveolar macrophages. Mediators Inflamm. 1999; 8: 43-51.
24. Rozy A, Czerniawska J, Stepniewska A, et al. Inflammatory markers in the exhaled breath condensate of patients with pulmonary sarcoidosis. J Physiol Pharmacol. 2006; 57 (Suppl 4): 335-340.
25. Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J. 2006; 27: 779-787.
26. Wahlström J, Katchar K, Wigzell H, et al. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med. 2001; 163: 115-121.
27. Zheng SG, Wang J, Horwitz DA. Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol. 2008; 180: 7112-7116.
28. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007; 148: 32-46.
29. Romagnani S. Human Th17 cells. Arthritis Res Ther. 2008; 10: 206.